Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease.
Lancet Haematol
; 2024 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-38964356
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Lancet Haematol
Year:
2024
Type:
Article